Aqemia Advances Epitranscriptomics Programs and Expands into Small-Molecule RNA Targeting with $7.4 Million Grant
Read moreAQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK
Read moreAQEMIA Boosts Series A Funding to €60M to Accelerate on its Proprietary Therapeutic Pipeline
Read more